Press release
Global DNA Sequencing Market is expected to Grow at a CAGR of ~18.02% by 2032 | DelveInsight
The DNA sequencing market is experiencing robust growth fueled by several critical factors, including the rising incidence of genetic disorders and cancer, increasing applications of precision medicine, expanding research in genomics, and ongoing advancements in sequencing technologies that have significantly reduced costs and turnaround times. As a result, the DNA sequencing market is projected to grow steadily between 2025 and 2032.DelveInsight's DNA sequencing market Insights report provides the current and forecast market analysis, individual leading DNA Sequencing companies' market shares, challenges, DNA sequencing market drivers, barriers, and trends, and key DNA sequencing companies in the market.
Explore the latest trends and growth drivers in the DNA Sequencing Market-download your sample report now https://www.delveinsight.com/report-store/dna-sequencing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Key Takeaways from the DNA Sequencing Market Report
• The global DNA sequencing market was valued at USD 10.70 billion in 2023 and is projected to grow at a CAGR of 18.02% from 2025 to 2032, reaching approximately USD 28.85 billion by 2032.
• As per DelveInsight estimates, North America is anticipated to dominate the DNA sequencing market during the forecast period.
• Notable DNA sequencing companies such as Agilent Technologies Inc., Biorad Laboratories Ltd, Danaher Corporation, F. Hoffmann-La Roche Ltd, Illumina Inc, PerkinElmer Inc, Merck & Co., Inc, QIAGEN, Thermo Fisher Scientific, PacBio, Macrogen Inc, Oxford Nanopore Technologies plc, CD Genomics, Takara Bio Inc, Promega Corporation, BGI, 10x Genomics, Eurofins Genomics, GENEWIZ (Azenta Life Sciences), and several others are currently operating in the DNA sequencing market.
• In January 2025, Tempus AI launched its FDA-approved xT CDx test nationwide. xT CDx is a 648-gene NGS-based in vitro diagnostic for solid tumor profiling, including microsatellite instability and companion diagnostics for colorectal cancer. Using a normal-matched approach, it improves accuracy in detecting cancer-driving mutations.
• In November 2024, Caris Life Sciences received FDA approval for its MI Cancer Seek assay, a companion diagnostic for multiple targeted therapies across various cancers. It is the first test to combine whole exome and whole transcriptome sequencing, analyzing both DNA and RNA to identify patients most likely to benefit from specific treatments. The test examines 228 genes for mutations, detects microsatellite instability, and measures tumor mutational burden using standard tumor tissue samples.
• In November 2024, HuidaGene Therapeutics, a global clinical-stage biotech company, received FDA clearance to advance HG202, its investigational CRISPR/Cas13 RNA-editing therapy for neovascular age-related macular degeneration (nAMD). Developed using the company's proprietary HG-PRECISE platform, HG202 harnesses AI and machine learning for rapid Cas protein discovery and metagenomic assembly predictions, enabling precise and efficient therapeutic development.
• In May 2022, Limaca Medical, a privately held company located in Israel devoted to enhancing endoscopic biopsy outcomes for patients with potentially life-threatening gastrointestinal tumors, gained FDA breakthrough device classification for its Precision GI endoscopic ultrasound biopsy device. Precision GI is deployed and operated through an instrument channel in the endoscope to biopsy a tumor.
To read more about the latest highlights related to the DNA sequencing market, get a snapshot of the key highlights entailed in the DNA sequencing market report here https://www.delveinsight.com/report-store/dna-sequencing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
DNA Sequencing Overview
DNA sequencing is a powerful molecular biology technique used to determine the precise order of nucleotides within a DNA molecule, enabling comprehensive insights into genetic information. It plays a crucial role in various applications, including clinical diagnostics, personalized medicine, cancer genomics, infectious disease detection, and evolutionary biology. Advances in next-generation sequencing (NGS) have drastically reduced costs and increased throughput, allowing for rapid and large-scale analysis of entire genomes or specific gene panels. This has accelerated research and clinical efforts in identifying disease-causing mutations, tailoring targeted therapies, and advancing precision medicine initiatives.
DNA Sequencing Market Insights
North America is expected to dominate the global DNA sequencing market, primarily driven by a high cancer burden, supportive regulatory policies, and advanced healthcare infrastructure. The rising incidence of cancers, such as breast cancer and other solid tumors, particularly in the United States-as indicated by the American Cancer Society and CDC-continues to boost the demand for next-generation sequencing in diagnostics and personalized medicine. Additionally, strong government initiatives like the $1.7 billion U.S. investment in COVID-19 variant tracking and genome sequencing have enhanced national sequencing capabilities. Coupled with increasing awareness and investments in genomic research and bioinformatics, these factors collectively contribute to the robust growth of the DNA sequencing market in North America.
To know more about why North America is leading the market growth in the DNA sequencing market, get a snapshot of the DNA sequencing market outlook here https://www.delveinsight.com/report-store/dna-sequencing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
DNA Sequencing Market Dynamics
The DNA sequencing market is experiencing significant growth, primarily driven by the rising prevalence of genetic disorders and the increasing adoption of precision medicine. Rare diseases, which affect about 1 in 17 people globally, are often genetic in nature and difficult to diagnose. This has led to growing demand for advanced sequencing technologies like whole genome sequencing, which can identify multiple variant types in a single test and improve diagnostic accuracy. National initiatives, such as the UK's plan to sequence 500,000 genomes, reflect this trend.
Simultaneously, the rise of precision medicine-tailoring cancer treatment based on genetic profiles-is fueling further demand for DNA sequencing. Technologies like next-generation sequencing enable comprehensive tumor analysis, aiding in targeted drug development and individualized therapy plans. However, challenges such as high costs and technical limitations like sequence alignment and read mapping may hinder market expansion.
Get a sneak peek at the DNA sequencing market dynamics @ https://www.delveinsight.com/report-store/dna-sequencing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Coverage: Global
Study Period: 2022 to 2032
DNA Sequencing Market CAGR: ~18.02%
Key DNA Sequencing Companies: Agilent Technologies Inc., Biorad Laboratories Ltd, Danaher Corporation, F. Hoffmann-La Roche Ltd, Illumina Inc, PerkinElmer Inc, Merck & Co., Inc, QIAGEN, Thermo Fisher Scientific, PacBio, Macrogen Inc, Oxford Nanopore Technologies plc, CD Genomics, Takara Bio Inc, Promega Corporation, BGI, 10x Genomics, Eurofins Genomics, GENEWIZ (Azenta Life Sciences), and others.
DNA Sequencing Market Segmentation
Market Segmentation By Products & Services: Instruments, Consumables, and Services.
Market Segmentation By Technology: Sanger Sequencing, Next-Generation Sequencing, and Long-Read Sequencing.
Market Segmentation By Application: Disease Diagnosis, Precision Medicine, and Research
Market Segmentation By End User: Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical Companies, and Academic Institutes.
Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
Which MedTech key players in the DNA sequencing market are set to emerge as the trendsetter, explore @ https://www.delveinsight.com/report-store/dna-sequencing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents
1. DNA Sequencing Market Report Introduction
2. DNA Sequencing Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. DNA Sequencing Market Key Factors Analysis
6. DNA Sequencing Market Porter's Five Forces Analysis
7. DNA Sequencing Market Layout
8. DNA Sequencing Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us
Trending Reports:
• Antibody Mediated Rejection Market: https://www.delveinsight.com/report-store/antibody-mediated-rejection-market
• Antiphospholipid Syndrome Aps Market: https://www.delveinsight.com/report-store/antiphospholipid-syndrome-aps-market
• Arthroscopic Shavers Market: https://www.delveinsight.com/report-store/arthroscopic-shavers-market
• Arthroscopy Devices Market: https://www.delveinsight.com/report-store/arthroscopy-devices-market
• Artificial Kidney Market: https://www.delveinsight.com/report-store/artificial-kidney-market
• Aspergillosis Market: https://www.delveinsight.com/report-store/aspergillosis-market
• Atherectomy Devices Market: https://www.delveinsight.com/report-store/atherectomy-devices-market
• Bacterial Pyogenic Meningitis Market: https://www.delveinsight.com/report-store/bacterial-pyogenic-meningitis-market
• Becker Muscular Dystrophy Market: https://www.delveinsight.com/report-store/becker-muscular-dystrophy-market
• Bile Duct Neoplasm Market: https://www.delveinsight.com/report-store/bile-duct-cancer-market
• Bipolar Depression Market: https://www.delveinsight.com/report-store/bipolar-disorder-manic-depression-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Bradycardia Treatment Devices Market: https://www.delveinsight.com/report-store/bradycardia-treatment-devices-market
• Bronchopulmonary Dysplasia Market: https://www.delveinsight.com/report-store/bronchopulmonary-dysplasia-market
• Bunion Market: https://www.delveinsight.com/report-store/bunion-market
• Cancer Anorexia Market: https://www.delveinsight.com/report-store/cancer-anorexia-market
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Cardiotoxicity Market: https://www.delveinsight.com/report-store/cardiotoxicity-market
• Carpal Tunnel Syndrome Market: https://www.delveinsight.com/report-store/carpal-tunnel-release-system-market
• Catheter-related Bloodstream Infections Market: https://www.delveinsight.com/report-store/catheter-related-bloodstream-infection-crbsi-market-size-analysis
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global DNA Sequencing Market is expected to Grow at a CAGR of ~18.02% by 2032 | DelveInsight here
News-ID: 4098494 • Views: …
More Releases from DelveInsight Business Research

Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibr …
DelveInsight, a leading business consulting and market research firm, is pleased to announce the successful completion of an Asset Prioritization project that enabled a mid-sized pharmaceutical client to identify, evaluate, and secure a high-value therapeutic asset for in-licensing in the Atrial Fibrillation (AF) space. The case study highlights how evidence-based insights, structured methodologies, and multi-layered evaluations supported the client in achieving its long-term strategic growth goals.
Objective of the Case Study
The…

Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestone …
(Albany, USA) - DelveInsight's newly released report, "Myopia Pipeline Insight 2025," delivers an in-depth assessment of the clinical trial landscape, regulatory progress, and therapeutic development trends shaping the Myopia therapeutics market. The analysis highlights ongoing clinical advancements, pipeline opportunities, and the potential impact of emerging therapies on patient care and market dynamics.
According to DelveInsight's evaluation, the Myopia pipeline remains highly active, with 8+ pharmaceutical and biotechnology companies investigating more than…

Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Risin …
The global biopsy devices market is poised for significant growth, with market size projected to increase from USD 5,813.16 million in 2024 to USD 10,812.77 million by 2032, expanding at a CAGR of 8.09% during 2025-2032. The robust expansion is being driven by the growing incidence of cancers, rising demand for minimally invasive diagnostic procedures, and rapid advancements in biopsy technologies.
Biopsy devices play a crucial role in disease diagnosis by…

Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven …
According to the latest market analysis, the global general surgery devices market is set for robust growth, increasing from USD 21,786.29 million in 2024 to USD 35,399.63 million by 2032, expanding at a CAGR of 6.34% during 2025-2032. This growth reflects a surge in surgical procedures, continuous technological advancements, and rising demand for minimally invasive and robotic-assisted surgical techniques across healthcare systems worldwide.
DelveInsight's General Surgery Devices Market Report 2032 provides…
More Releases for DNA
High-Quality Plasmid DNA Fuels Growth in Global DNA Plasmid Manufacturing Market
🌍 Market Overview
The DNA Plasmid Manufacturing Market is experiencing robust growth as advancements in cell & gene therapy, DNA vaccines, and genetic engineering continue to expand globally. Plasmid DNA plays a critical role as a raw material in the development of advanced therapies, fueling demand across biopharmaceutical research and production.
Key factors driving the market include:
Increasing adoption of gene and cell therapies
Rising prevalence of chronic and rare genetic disorders
Expansion of DNA-based…
DNA Synthesis Market Increasing Demand for Synthetic Genes and DNA Sequences
As demonstrated by Precision Business Insights (PBI), the latest report, the global DNA synthesis market was valued at USD 3,702.0 million in 2023 and is expected to reach USD 10,289.5 million by 2029, growing at a CAGR of 18.6% during the forecast period 2024-2030. The key drivers for the growth of the global DNA synthesis market include increasing demand for synthetic genes and DNA sequences, growing applications in the agriculture…
Wealth DNA Code Review Legit Price? (Wealth Manifestation DNA Code Audio Frequen …
Wealth DNA Code Wealth DNA Code is a digital program with seven minutes of soundtracks that manifest and listen to daily to activate the "Wealth DNA," which is part of your DNA to help you attract wealth by making money a part of your mentality and making your dreams to come true.
https://bit.ly/Visit-The-Official-Website-Here-To-Order-Wealth-DNA-Code
Making money, creating assets as well as increasing wealth are the primary objectives that every human being has to…
DNA Paternity Testing Market Size [2022-2029] -DNA Diagnostics Center, EasyDNA, …
A recent market research report added to repository of MR Accuracy Reports is an in-depth analysis of global DNA Paternity Testing. On the basis of historic growth analysis and current scenario of DNA Paternity Testing place, the report intends to offer actionable insights on global market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights drawn from data serve as excellent…
DNA Paternity Testing Market Trends 2020 | Growth by Top Companies: DNA Diagnost …
The report begins with the overview of the DNA Paternity Testing Market and offers throughout development. It presents a comprehensive analysis of all the regional and major player segments that gives closer insights upon present market conditions and future market opportunities along with drivers, trending segments, consumer behaviour, pricing factors and market performance and estimation. The forecast market information, SWOT analysis, DNA Paternity Testing market scenario, and feasibility study are…
DNA Paternity Testing Market Rapidly Growing in Healthcare, Competitor Analysis …
The exclusive research report on the Global DNA Paternity Testing Market 2020 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market. Global DNA Paternity Testing Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe.
Overview of Global DNA Paternity Testing Market:
This report studies the Global DNA Paternity Testing…